advertisement
11.16 Vehicles, delivery systems, pharmacokinetics, formulation (16)
Showing records 1 to 16
Search within classification 11.16 Vehicles, delivery systems, pharmacokinetics, formulation52476 Conjunctivochalasis as a Contributing Factor for the Development of Ocular Surface Disease in Medically Treated Glaucoma Patients
Kocabeyoglu S; Mocan MC; Irkec M; Orhan M; Karakaya J
Journal of Glaucoma 2014; 23: 333-336
52537 The effect of Rho-associated kinase inhibition on the ocular penetration of timolol maleate
Arnold JJ; Hansen MS; Gorman GS; Inoue T; Rao V; Spellen S; Hunsinger RN; Chapleau CA; Pozzo-Miller L; Stamer WD; Challa P
Investigative Ophthalmology and Visual Science 2013; 54: 1118-1126
53184 Tear clearance and ocular symptoms in patients treated with preservative-free prostaglandins
Giménez-Gómez R; García-Catalán MR; Gallardo-Galera JM
Archivos de la Sociedad Española de Oftalmologia 2013; 88: 88-91
52957 Localisation and quantification of benzalkonium chloride in eye tissue by TOF-SIMS imaging and liquid chromatography mass spectrometry
Desbenoit N; Schmitz-Afonso I; Baudouin C; Laprévote O; Touboul D; Brignole-Baudouin F; Brunelle A
Analytical and bioanalytical chemistry 2013; 405: 4039-4049
52484 Preservative-free treatment in glaucoma: who, when, and why
Stalmans I; Sunaric Mégevand G; Cordeiro MF; Hommer A; Rossetti L; Goñi F; Heijl A; Bron A
European Journal of Ophthalmology 2013; 23: 0
52600 Nanotechnology and glaucoma: little particles for a big disease
Pita-Thomas DW; Goldberg JL
Current Opinions in Ophthalmology 2013; 24: 130-135
52947 Preformulation study of methazolamide for topical ophthalmic delivery: physicochemical properties and degradation kinetics in aqueous solutions
Jiang S; Wang F; Zhu S; Zhang X; Guo Z; Li R; Xu Q
International Journal of Pharmaceutics 2013; 448: 390-393
52814 Nanotechnology approaches for ocular drug delivery
Xu Q; Kambhampati SP; Kannan RM
Middle East African Journal of Ophthalmology 2013; 20: 26-37
52417 Safety Assessment of Subconjunctivally Implanted Devices Containing Latanoprost in Dutch-Belted Rabbits
Jessen BA; Shiue MH; Kaur H; Miller P; Leedle R; Guo H; Evans M
Journal of Ocular Pharmacology and Therapeutics 2013; 29: 574-585
52437 Preservative Exposure and Surgical Outcomes in Glaucoma Patients: The PESO Study
Boimer C; Birt CM
Journal of Glaucoma 2013; 22: 730-735
52612 Glaucoma therapy and ocular surface disease: current literature and recommendations
Anwar Z; Wellik SR; Galor A
Current Opinions in Ophthalmology 2013; 24: 136-143
52966 Comparative cross-sectional analysis of the effects of topical antiglaucoma drugs on the ocular surface
Lee S; Kim MK; Choi HJ; Wee WR; Kim DM
Advances in Therapy 2013; 30: 420-429
52452 Betaxolol hydrochloride loaded chitosan nanoparticles for ocular delivery and their anti-glaucoma efficacy
Jain K; Kumar RS; Sood S; Dhyanandhan G
Current Drug Delivery 2013; 10: 493-499
53193 Preservative-free tafluprost in the treatment of naive patients with glaucoma and ocular hypertension
Lanzl I; Hamacher T; Rosbach K; Ramez MO; Rothe R; Růžičková E; Karhanová M; Kimmich F
Clinical Ophthalmology 2013; 7: 901-910
52816 Ocular surface tolerability of prostaglandin analogs and prostamides in patients with glaucoma or ocular hypertension
Crichton AC; Vold S; Williams JM; Hollander DA
Advances in Therapy 2013; 30: 260-270
53079 A comparative study of the safety and efficacy effect of 5-fluorouracil or mitomycin C mounted biological delivery membranes in a rabbit model of glaucoma filtration surgery
Wu Z; Li S; Wang N; Liu W
Clinical Ophthalmology 2013; 7: 655-662
